TY - JOUR
T1 - Vaccinations for Patients With Cancer and Cancer Survivors
AU - Rodriguez, Maria Alma
N1 - Publisher Copyright:
© 2022 National Comprehensive Cancer Network, Inc. All rights reserved
PY - 2022/6
Y1 - 2022/6
N2 - Patients with cancer and cancer survivors are vulnerable to infection, rendering vaccination a necessary intervention. The vaccination process represents a unique challenge in these populations-it is often impossible or impractical to delay the start of cancer treatment for immunizations, and vaccines may fail to trigger an appropriate protective immune response in immunocompromised patients and cancer survivors, with residual immune deficits. Additionally, live attenuated vaccines are contraindicated due to an increased risk of prolonged shedding and disease presence. The current NCCN Guidelines for Survivorship, which reflect the most up-to-date, evidence-based data relating to survivorship, detail the appropriate immunization practices in these highly susceptible populations.
AB - Patients with cancer and cancer survivors are vulnerable to infection, rendering vaccination a necessary intervention. The vaccination process represents a unique challenge in these populations-it is often impossible or impractical to delay the start of cancer treatment for immunizations, and vaccines may fail to trigger an appropriate protective immune response in immunocompromised patients and cancer survivors, with residual immune deficits. Additionally, live attenuated vaccines are contraindicated due to an increased risk of prolonged shedding and disease presence. The current NCCN Guidelines for Survivorship, which reflect the most up-to-date, evidence-based data relating to survivorship, detail the appropriate immunization practices in these highly susceptible populations.
UR - http://www.scopus.com/inward/record.url?scp=85131941959&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85131941959&partnerID=8YFLogxK
U2 - 10.6004/jnccn.2022.5014
DO - 10.6004/jnccn.2022.5014
M3 - Article
AN - SCOPUS:85131941959
SN - 1540-1405
VL - 20
SP - 607
EP - 610
JO - JNCCN Journal of the National Comprehensive Cancer Network
JF - JNCCN Journal of the National Comprehensive Cancer Network
IS - 5.5
ER -